Koti M

No ORCID on file · 20 papers in corpus · active 2016-2024

Study types

  • article 9
  • review 5
  • other 4
  • preprint 2

Condition tags

  • endometriosis 20
  • chronic_pelvic_pain 3
  • infertility 3
  • die_deep_infiltrating 1
other 2024
eLife ·doi:10.7554/eLife.96523

Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecular mechanis…

preprint 2024
·doi:10.21203/rs.3.rs-3486655/v2

Abstract Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecula…

other 2024
F&S science ·doi:10.1016/j.xfss.2024.10.001

OBJECTIVE: To determine whether tertiary lymphoid structures (TLSs), which reflect organized immune cell aggregates present in non-lymphoid tissues, are consistent features of endometriosis lesions. DESIGN: Detailed histopathological analy…

preprint 2023
·doi:10.1101/2023.10.11.561929

Abstract Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecular…

article 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.961599

Endometriosis is an estrogen dependent, chronic inflammatory disease characterized by the growth of endometrial lining outside of the uterus. Mast cells have emerged as key players in regulating not only allergic responses but also other me…

review 2022
Trends in molecular medicine ·doi:10.1016/j.molmed.2022.04.006

IL-33 is a member of the IL-1 family and was first identified as an alarmin that acts at mucosal barrier sites. However, IL-33 is now understood to be a pleiotropic cytokine that acts on a variety of immune and non-immune cell types to prom…

review 2022
Journal of cannabis research ·doi:10.1186/s42238-022-00163-8

Endometriosis patients experience debilitating chronic pain, and the first-line treatment is ineffective at managing symptoms. Although surgical removal of the lesions provides temporary relief, more than 50% of the patients experience dise…

article 2022
F&S science ·doi:10.1016/j.xfss.2022.04.007

OBJECTIVE: To identify immune cells, cytokines, and immune cell transcriptome in the menstrual effluent (ME) of women with endometriosis compared with that of healthy donors. DESIGN: Live immune cells were isolated from human ME samples an…

other 2021
JCI insight ·doi:10.1172/jci.insight.149699

Chronic inflammation and localized alterations in immune cell function are suspected to contribute to the progression of endometriosis and its associated symptoms. In particular, the alarmin IL-33 is elevated in the plasma, peritoneal fluid…

article 2021
F&S science ·doi:10.1016/j.xfss.2021.09.005

OBJECTIVE: To determine the involvement of the endocannabinoid (EC) family member in the pathophysiology of endometriosis (EMS). DESIGN: Mass spectrometry analysis of plasma and tissue samples from patients with EMS, controls, and a mouse …

article 2021
Frontiers in reproductive health ·doi:10.3389/frph.2021.726936

Endometriosis (EM) is characterized by the growth of endometrium-like tissue outside the uterus, leading to chronic inflammation and pelvic pain. Lesion proliferation, vascularization, and associated inflammation are the hallmark features o…

other 2020
Frontiers in immunology ·doi:10.3389/fimmu.2020.00108

Endometriosis is a debilitating gynecological disease characterized by the extrauterine presence of endometrial-like tissues located on the peritoneal membrane and organs of the pelvic cavity. Notably, dysfunctional immune activation in wom…

article 2019
JCI insight ·doi:10.1172/jci.insight.128846

With multifactorial etiologies, combined with disease heterogeneity and a lack of suitable diagnostic markers and therapy, endometriosis remains a major reproductive health challenge. Extracellular vesicles (EVs) have emerged as major contr…

article 2019
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.201902272r

Endometriosis is a chronic inflammatory, gynecological disease characterized by the presence of endometrial-like tissue lesions outside of the uterus. Neutrophils are elevated in the systemic circulation and peritoneal fluid of endometriosi…

review 2018
Trends in molecular medicine ·doi:10.1016/j.molmed.2018.07.004

Endometriosis is a chronic, inflammatory, estrogen-dependent disease characterized by the growth of endometrial tissue outside of the uterine cavity. Although the etiology of endometriosis remains elusive, immunological dysfunction has been…

article 2017
Scientific reports ·doi:10.1038/s41598-017-06081-7

Endometriosis, a major reproductive pathology affecting 8-10% of women is characterized by chronic inflammation and immune dysfunction. Human antigen R (HuR) and Tristetraprolin (TTP) are RNA binding proteins that competitively bind to cyto…

article 2017
Scientific reports ·doi:10.1038/s41598-017-18224-x

Endometriosis is a debilitating condition that is categorized by the abnormal growth of endometrial tissue outside the uterus. Although the pathogenesis of this disease remains unknown, it is well established that endometriosis patients exh…

review 2017
The American journal of pathology ·doi:10.1016/j.ajpath.2017.01.017

RNA-binding proteins are key regulatory molecules involved primarily in post-transcriptional gene regulation of RNAs. Post-transcriptional gene regulation is critical for adequate cellular growth and survival. Recent reports have shown key …

article 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.07.005

ObjectiveTo determine if the molecular profiles of endometriotic lesions contain informative measures of inflammation and immune dysfunction that may contribute to better understanding of the interplay between immune dysfunction and inflamm…

review 2016
Oncotarget ·doi:10.18632/oncotarget.12577

// Jessica E. Miller 1 , Soo Hyun Ahn 1 , Stephany P. Monsanto 1 , Kasra Khalaj 1 , Madhuri Koti 1 and Chandrakant Tayade 1 1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada Correspondence to: …